泰嘉股份(002843.SZ)擬推2021年員工持股計劃 籌資上限為4296.80萬元
格隆匯 3 月 25日丨泰嘉股份(002843.SZ)披露2021年員工持股計劃(草案),該員工持股計劃規模不超過1048.00萬股,約佔該員工持股計劃草案公吿日公司股本總額2.1億股的4.99%,擬籌集資金總額上限為4296.80萬元,具體份額根據實際出資繳款金額確定。
該員工持股計劃購買回購股票的價格為4.10元/股,不低於公司回購股份均價的50%。參加該員工持股計劃的對象範圍為公司(含控股子公司)的董事(不含獨立董事)、監事、高級管理人員、核心經營人才和核心技術人才,總人數共計不超過20人,具體參加人數、名單將根據員工實際繳款情況確定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.